Your browser doesn't support javascript.
loading
Impact of Copy Number Variants and Polygenic Risk Scores on Psychopathology in the UK Biobank.
Mollon, Josephine; Schultz, Laura M; Huguet, Guillaume; Knowles, Emma E M; Mathias, Samuel R; Rodrigue, Amanda; Alexander-Bloch, Aaron; Saci, Zohra; Jean-Louis, Martineau; Kumar, Kuldeep; Douard, Elise; Almasy, Laura; Jacquemont, Sebastien; Glahn, David C.
Affiliation
  • Mollon J; Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: josephine.mollon@childrens.harvard.edu.
  • Schultz LM; Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Huguet G; Department of Pediatrics, Université de Montréal, Montreal, Quebec, Canada; Department of Pediatrics, Center Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Quebec, Canada.
  • Knowles EEM; Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Mathias SR; Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Rodrigue A; Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Alexander-Bloch A; Department of Child and Adolescent Psychiatry and Behavioral Science, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Lifespan Brain Institute, The Children's Hospital of Philadelphia and Penn Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Neurodevelopment and
  • Saci Z; Department of Pediatrics, Center Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Quebec, Canada.
  • Jean-Louis M; Department of Pediatrics, Center Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Quebec, Canada.
  • Kumar K; Department of Pediatrics, Center Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Quebec, Canada.
  • Douard E; Department of Pediatrics, Université de Montréal, Montreal, Quebec, Canada; Department of Pediatrics, Center Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Quebec, Canada.
  • Almasy L; Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Department of Genetics, Perelman School of Medicine, Penn-CHOP Lifespan Brain Institute, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Jacquemont S; Department of Pediatrics, Université de Montréal, Montreal, Quebec, Canada; Department of Pediatrics, Center Hospitalier Universitaire Sainte-Justine Research Center, Montreal, Quebec, Canada.
  • Glahn DC; Department of Psychiatry, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Olin Neuropsychiatry Research Center, Institute of Living, Hartford, Connecticut.
Biol Psychiatry ; 94(7): 591-600, 2023 10 01.
Article in En | MEDLINE | ID: mdl-36764568
BACKGROUND: Our understanding of the impact of copy number variants (CNVs) on psychopathology and their joint influence with polygenic risk scores (PRSs) remains limited. METHODS: The UK Biobank recruited 502,534 individuals ages 37 to 73 years living in the United Kingdom between 2006 and 2010. After quality control, genotype data from 459,855 individuals were available for CNV calling. A total of 61 commonly studied recurrent neuropsychiatric CNVs were selected for analyses and examined individually and in aggregate (any CNV, deletion, or duplication). CNV risk scores were used to quantify intolerance of CNVs to haploinsufficiency. Major depressive disorder and generalized anxiety disorder PRSs were generated for White British individuals (N = 408,870). Mood/anxiety factor scores were generated using item-level questionnaire data (N = 501,289). RESULTS: CNV carriers showed higher mood/anxiety scores than noncarriers, with the largest effects seen for intolerant deletions. A total of 11 individual deletions and 8 duplications were associated with higher mood/anxiety. Carriers of the 9p24.3 (DMRT1) duplication showed lower mood/anxiety. Associations remained significant for most CNVs when excluding individuals with psychiatric diagnoses. Nominally significant CNV × PRS interactions provided preliminary evidence that associations between select individual CNVs, but not CNVs in aggregate, and mood/anxiety may be modulated by PRSs. CONCLUSIONS: CNVs associated with risk for psychiatric disorders showed small to large effects on dimensional mood/anxiety scores in a general population cohort, even when excluding individuals with psychiatric diagnoses. CNV × PRS interactions showed that associations between select CNVs and mood/anxiety may be modulated by PRSs.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depressive Disorder, Major / Mental Disorders Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Biol Psychiatry Year: 2023 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depressive Disorder, Major / Mental Disorders Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Biol Psychiatry Year: 2023 Document type: Article Country of publication: United States